Abstract
The superoxide anion radical is a highly reactive toxic species produced during metabolic processes. Several copper (II) complexes with peptides are known to show superoxide dismutase (SOD) activity but those having a peptide with a non-natural amino acid are limited. The synthesis of HisAibGly peptide and its complexation with copper (II) ions has been reported. The interaction of the synthetic peptide with Cu(II) was studied by electron spray ionization-mass (ESIMS), circular dichroism (CD), absorption (UV-Vis) and electron paramagnetic resonance (EPR) spectroscopic methods. The solution studies and species distribution were performed by both spectrophotometric and potentiometric methods. The studies were performed at 25 ± 0.1 °C with constant ionic strength (μ = 0.1 M NaNO3) in aqueous solution using Bjerrum- Calvins pH-titration technique as adopted by Irving and Rossotti for binary systems. The species distribution stidies indicated that the complexation occurred from 3-11 pH and a three nitrogen coordinated species predominates at 8-9 whereas a four nitrogen coordinated species was formed between pH 9-11. The copper-peptide complex was tested for SOD activity using xanthine-xanthine oxidase ‐ nitroblue tetrazolium (NBT) methods.
Protein & Peptide Letters
Title: Copper (II) – HisAibGly Complex and Its Superoxide Dismutase Activity (Suplementary Material)
Volume: 17 Issue: 2
Author(s): Raj K. Singh, Sudhanand Prasad and Udai P. Singh
Affiliation:
Abstract: The superoxide anion radical is a highly reactive toxic species produced during metabolic processes. Several copper (II) complexes with peptides are known to show superoxide dismutase (SOD) activity but those having a peptide with a non-natural amino acid are limited. The synthesis of HisAibGly peptide and its complexation with copper (II) ions has been reported. The interaction of the synthetic peptide with Cu(II) was studied by electron spray ionization-mass (ESIMS), circular dichroism (CD), absorption (UV-Vis) and electron paramagnetic resonance (EPR) spectroscopic methods. The solution studies and species distribution were performed by both spectrophotometric and potentiometric methods. The studies were performed at 25 ± 0.1 °C with constant ionic strength (μ = 0.1 M NaNO3) in aqueous solution using Bjerrum- Calvins pH-titration technique as adopted by Irving and Rossotti for binary systems. The species distribution stidies indicated that the complexation occurred from 3-11 pH and a three nitrogen coordinated species predominates at 8-9 whereas a four nitrogen coordinated species was formed between pH 9-11. The copper-peptide complex was tested for SOD activity using xanthine-xanthine oxidase ‐ nitroblue tetrazolium (NBT) methods.
Export Options
About this article
Cite this article as:
Singh K. Raj, Prasad Sudhanand and Singh P. Udai, Copper (II) – HisAibGly Complex and Its Superoxide Dismutase Activity (Suplementary Material), Protein & Peptide Letters 2010; 17 (2) . https://dx.doi.org/10.2174/092986610790226012
DOI https://dx.doi.org/10.2174/092986610790226012 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Review on Hematopoietic Stem Cell Treatment for Epilepsy
CNS & Neurological Disorders - Drug Targets The Secretin/Pituitary Adenylate Cyclase-Activating Polypeptide/ Vasoactive Intestinal Polypeptide Superfamily in the Central Nervous System
Central Nervous System Agents in Medicinal Chemistry CRISPR/Cas9 Genome Editing Tool: A Promising Tool for Therapeutic Applications on Respiratory Diseases
Current Gene Therapy Current Understanding of In-stent Restenosis and the Potential Benefit of Drug Eluting Stents
Current Drug Targets - Cardiovascular & Hematological Disorders Chemistry and Health Effects of Bioactive Compounds in Selected Culinary Aromatic Herbs
Current Nutrition & Food Science Strategies for Developing Tuberculosis Vaccines: Emerging Approaches
Current Drug Targets Editorial (Thematic Issue: Signal Transduction, Targeted Therapy and Cancer: From Bench to Clinics)
Current Pharmaceutical Design Post-Translational Modifications of PTEN and their Potential Therapeutic Implications
Current Cancer Drug Targets Biology of Cholesterol Lowering in Atherosclerotic Plaques
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Radiation-Induced Oral Mucositis in Head and Neck Cancer Patients. Five Years Literature Review
Reviews on Recent Clinical Trials Epidermolysis Bullosa: The Pediatricians Role
Current Pediatric Reviews High Order Texture-Based Analysis in Biomedical Images
Current Medical Imaging Synthesis of Various S-S Linked Symmetric Bisazaheterocycles: A Review
Mini-Reviews in Organic Chemistry Pharmacokinetics of Topical Ocular Drug Delivery: Potential Uses for the Treatment of Diseases of the Posterior Segment and Beyond
Current Drug Metabolism Design, Synthesis and Anticancer Activity Against the MCF-7 Cell Line of Benzo-Fused 1,4-Dihetero Seven- and Six-Membered Tethered Pyrimidines and Purines
Current Medicinal Chemistry Anaemia in Diabetes: An Emerging Complication of Microvascular Disease
Current Diabetes Reviews Antibody-directed Double Suicide Gene Therapy Targeting of MUC1- Positive Leukemia Cells In Vitro and In Vivo
Current Gene Therapy PEO-PPO Block Copolymers for Passive Micellar Targeting and Overcoming Multidrug Resistance in Cancer Therapy
Current Drug Targets Amniotic Fluid Stem Cells: a Promising Therapeutic Resource for Cell-Based Regenerative Therapy
Current Pharmaceutical Design Role of Defensins and Cathelicidin LL37 in Auto-Immune and Auto- Inflammatory Diseases
Current Pharmaceutical Biotechnology